Cannabis testing market expected to secure notable revenue share between 2022 and 2030 – mbu timeline


According to the Market Statsville Group (MSG), the global cannabis testing market was rated at $1,224.4 million in 2021 and should reach $3,009.9 million by 2030recording a 11.9% CAGR from 2022 to 2030. Rising demand for legalization of cannabis in several countries for medical purposes and increasing adoption of LIMS in cannabis testing laboratories are the major factors driving the growth of the cannabis testing market. Additionally, many leading pharmaceutical companies seeking new technologies to collaborate with testing laboratories to market and distribute medical cannabis products are also expected to drive the market growth. However, the high start-up cost of cannabis testing labs is expected to restrain the market growth. These laboratories must make significant investments in advanced and expensive analytical equipment in order to purchase and maintain them. Emerging economies in developing regions such as LATAM and Asia-Pacific, on the other hand, are expected to provide new opportunities for market players.

The outbreak of the COVID-19 pandemic has had a positive and negative impact on the pharmaceutical and life sciences industry. Certain market segments were more impacted due to weak demand for consumables, instruments and reagents as well as due to supply chain disruptions and trade restrictions. Overall, labs around the world were closed or operating at reduced capacity. Instead of performing routine operations, labs that were open focused primarily on COVID-19 testing.

Get Full Sample PDF Copy of Report:

Global Cannabis Testing Market Definition

Cannabis testing refers to the analysis whereby an individual sample of cannabis can be examined to determine levels of THC, CBD and terpenes as well as contaminants and impurities such as residual solvents, mold, disease, parasites or pesticide residues.

Global Cannabis Testing Market Dynamics

Drivers: Rapid urbanization and industrialization

Global cannabis testing is in its mature phase. The best companies in the market have embraced product endorsement, collaboration and agreement as development strategies in the competitive market. The information provided in this report is obtained through press releases from major companies and is limited to publicly available information.

LIMS can increase the efficiency of cannabis testing laboratories and reduce procedural errors by enforcing SOPs, automating workflows, and tightening process controls. LIMS ensures seamless data exchange with analytical instruments by integrating instruments, preventing manual errors, and maintaining data integrity. Thus, LIMS software plays a crucial role in cannabis testing labs by managing, streamlining and automating QA/QC processes.

Constraints: High start-up costs for cannabis testing labs

Laboratories must make significant investments to obtain and maintain advanced and expensive analytical equipment. Equipment standardization and upgrades, software requirements, certifications (such as ISO certification protocols), accreditations and the need for qualified specialists further increase the cost of operations. The impact of these factors is heightened as many banks deny funding or any other form of assistance to these labs due to ambiguity in the cannabis testing industry and lines of credit are not available to laboratory owners/operators.

Scope of the Global Cannabis Testing Market

The study categorizes the cannabis testing market based on product, type of test, and end users regionally and globally..

By Product Perspective (Sales/Revenue, USD million, 20172030)

  • Instruments
  • Consumables
  • Software

By type of test (Sales/Revenue, USD million, 20172030)

  • Heavy metal tests
  • Microbial analysis
  • Power test
  • Residual screening
  • Others

Inquire Before Buy @:

From end-user perspectives (Sales/Revenue, USD million, 20172030)

  • Cannabis growers/producers
  • Cannabis manufacturers
  • Others

Outlook by region (Sales/Revenue, USD million, 20172030)

  • North America
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • The rest of Europe

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia and New Zealand
    • Rest of Asia-Pacific

  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America

  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • North Africa
    • Rest of MEA

The consumables segment represents the largest market share, by product

On the basis of product, the cannabis testing market is classified into instruments, consumables and software. The consumables segment was the largest contributor to the market, with a market share of 58.5% in 2021. Consumables are the largest contributor segment in the global market, owing to the frequent use of consumables for testing of cannabis.

Cannabis testing involves the use of several medical devices to detect the quality of cannabis. This helps identify applications of cannabis for multiple medical purposes. Many companies offer columns, supplies and accessories, as well as sample handling products for cannabis testing. The repetitive use of these consumables is one of the main growth drivers for this segment. Additionally, high demand for the following instruments such as chromatography and spectroscopy across the globe is contributing to the rise in demand for cannabis testing consumables, which is driving the growth of the market.

Asia Pacific represents the highest CAGR over the forecast period

On the basis of region, the global cannabis testing market has been segmented into North America, AsiaPacific, Europe, South America, Middle East and Africa. Globally, Asia-Pacific is estimated to hold the highest CAGR of 12.8% in the global cannabis testing market during the forecast period. Asia-Pacific includes countries like China, Japan, and Australia. Asia-Pacific is a densely populated region, with India and China being the most populated countries. The recent legalization of cannabis for medical and therapeutic purposes in many Asian countries, combined with the high venture capital funding for cannabis testing, is primarily responsible for the boom in cannabis testing market in Asia-Pacific.

Request for Full Table of Contents and Figures & Graphs @

Asia-Pacific is the lucrative region for cannabis testing after LAMEA, due to increased adoption of LIMS and legalization of cannabis for medical and recreational use and increased demand via domestic manufacturing , which is further driving the growth of the market. For example, the increasing adoption of the LIMS technique is helping to improve the transparency of the status of laboratory work, reduce costs and improve efficiency, provide the flexibility to meet new requirements and improve the quality and compliance. The penetration of information technology and the growing demand for data management and standardization are increasing the number of LIMS vendors in the market.

Key Market Players in the Global Cannabis Testing Market

Global cannabis testing is in its mature stage. The best companies in the market have embraced product endorsement, collaboration and agreement as development strategies in the competitive market. The information provided in this report is obtained through press releases from major companies and is limited to publicly available information.

Key Players of the Global Cannabis Testing Market are:

Request for Report Description @


Comments are closed.